The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development

Jonathan Hullmann1, Christopher J Traynham2, Ryan C Coleman2

  • 1Thomas Jefferson University, Philadelphia, PA 19107, United States.

Insights

Heart failure (HF) involves G protein-coupled receptors (GPCRs) regulated by GRK kinases. This review explores non-canonical GRK signaling in HF and potential therapies targeting GRK2 and GRK5.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Pharmacology

Background:

  • Heart failure (HF) is a global health crisis with high mortality and morbidity.
  • G protein-coupled receptors (GPCRs) are key regulators of cardiovascular function.
  • GPCR kinases (GRKs) desensitize activated GPCRs; GRK2 and GRK5 are upregulated in HF.

Purpose of the Study:

  • To review recent findings on non-canonical GRK signaling in heart failure.
  • To present potential therapeutic strategies for targeting GRKs in HF.

Main Methods:

  • Literature review of studies on GRK signaling in cardiovascular disease.
  • Analysis of molecular mechanisms underlying GRK action in the failing heart.
  • Evaluation of emerging therapeutic approaches for HF.

Main Results:

  • GRK2 and GRK5 are critical mediators of molecular changes in the failing heart.
  • Non-canonical signaling pathways of GRKs in HF are increasingly recognized.
  • Emerging therapies include small molecule inhibitors, microRNAs, and gene therapy.

Conclusions:

  • Understanding non-canonical GRK signaling is crucial for developing novel HF treatments.
  • Targeting GRK2 and GRK5 offers promising therapeutic avenues for heart failure.
  • Future research should focus on translating these findings into clinical applications.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.3K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

2.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
6.8K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K